PMDA — authorised 25 March 2020
- Marketing authorisation holder: Daiichi Sankyo Company, Limited
- Status: approved
🇯🇵 Enhertu in Japan
PMDA authorised Enhertu on 25 March 2020
Marketing authorisation
Enhertu in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in Japan
Frequently asked questions
Is Enhertu approved in Japan?
Yes. PMDA authorised it on 25 March 2020.
Who is the marketing authorisation holder for Enhertu in Japan?
Daiichi Sankyo Company, Limited holds the Japanese marketing authorisation.